benzyl 4-oxo-4-[5'-aminosulfamoyl-5'-deoxy-2',3'-O-isopropylidene-adenosine]-butyrate | 548483-90-5

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: benzyl 4-oxo-4-[5'-aminosulfamoyl-5'-deoxy-2',3'-O-isopropylidene-adenosine]-butyrate
• CAS: 548483-90-5
• 化学式: C₂₄H₂₈N₆O₉S
• 分子量: 576.587
• InChiKey: TZURZADLIQPYEU-NSOPBCBCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.73
• 重原子数：
  40.0
• 可旋转键数：
  10.0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  196.08
• 氢给体数：
  2.0
• 氢受体数：
  14.0

反应信息

• 作为反应物：
  描述：

  benzyl 4-oxo-4-[5'-aminosulfamoyl-5'-deoxy-2',3'-O-isopropylidene-adenosine]-butyrate 在 三氟乙酸 作用下， 反应 3.0h， 以89%的产率得到benzyl 4-oxo-4-[5'-aminosulfamoyl-5'-deoxyadenosine]-butyrate
  参考文献：
  名称：

  Synthesis and Characterization of an N-Acylsulfonamide Inhibitor of Human Asparagine Synthetase

  摘要：

  The synthesis of N-acylsulfonamide 6, which is an analogue of beta-aspartyl-AMP, is described. This compound appears to be the first and only potent inhibitor of human asparagine synthetase that has been described to date. The N-acylsulfonamide 6 exhibits slow-onset inhibition kinetics, with a K-1* of 728 nM. Preparation and characterization of two additional N-acylsulfonamide analogues has also demonstrated the importance of hydrogen-bonding interactions in the recognition of the AS inhibitor with the enzyme. These observations provide the basis for the discovery of new compounds with application in the treatment of drug-resistant leukemia.

  DOI：

  10.1021/ol034212n
• 作为产物：
  描述：

  琥珀酸苄酯 、 腺苷,2',3'-O-(1-甲基亚乙基)-,5'-氨基磺酸酯 在 4-二甲氨基吡啶 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 乙腈 为溶剂， 以66%的产率得到benzyl 4-oxo-4-[5'-aminosulfamoyl-5'-deoxy-2',3'-O-isopropylidene-adenosine]-butyrate
  参考文献：
  名称：

  Synthesis and Characterization of an N-Acylsulfonamide Inhibitor of Human Asparagine Synthetase

  摘要：

  The synthesis of N-acylsulfonamide 6, which is an analogue of beta-aspartyl-AMP, is described. This compound appears to be the first and only potent inhibitor of human asparagine synthetase that has been described to date. The N-acylsulfonamide 6 exhibits slow-onset inhibition kinetics, with a K-1* of 728 nM. Preparation and characterization of two additional N-acylsulfonamide analogues has also demonstrated the importance of hydrogen-bonding interactions in the recognition of the AS inhibitor with the enzyme. These observations provide the basis for the discovery of new compounds with application in the treatment of drug-resistant leukemia.

  DOI：

  10.1021/ol034212n